X-116172354-T-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000686.5(AGTR2):​c.74T>A​(p.Ile25Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000456 in 1,097,557 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 0.0000046 ( 0 hom. 1 hem. )

Consequence

AGTR2
NM_000686.5 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.450
Variant links:
Genes affected
AGTR2 (HGNC:338): (angiotensin II receptor type 2) The protein encoded by this gene belongs to the G-protein coupled receptor 1 family, and functions as a receptor for angiotensin II. It is an intergral membrane protein that is highly expressed in fetus and in neonates, but scantily in adult tissues, except brain, adrenal medulla, and atretic ovary. This receptor has been shown to mediate programmed cell death and this apoptotic function may play an important role in developmental biology and pathophysiology. Mutations in this gene are been associated with X-linked cognitive disability. Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and SARS-CoV-2 infection results in down-regulation of angiotensin converting enzyme-2 (ACE2) receptors, the effects of which, triggers serious inflammatory lesions in the tissues involved, primarily in the lungs. The inflammatory reaction appears to be mediated by angiotensin II derivatives, including the angiotensin AT2 receptor which has been found to be upregulated in bronchoalveolar lavage samples from Coronavirus disease 2019 (COVID19) patients. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07319206).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
AGTR2NM_000686.5 linkuse as main transcriptc.74T>A p.Ile25Asn missense_variant 3/3 ENST00000371906.5 NP_000677.2 P50052
AGTR2NM_001385624.1 linkuse as main transcriptc.74T>A p.Ile25Asn missense_variant 2/2 NP_001372553.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
AGTR2ENST00000371906.5 linkuse as main transcriptc.74T>A p.Ile25Asn missense_variant 3/31 NM_000686.5 ENSP00000360973.4 P50052
AGTR2ENST00000681852.1 linkuse as main transcriptc.74T>A p.Ile25Asn missense_variant 2/2 ENSP00000505750.1 P50052
AGTR2ENST00000680409.1 linkuse as main transcriptn.542T>A non_coding_transcript_exon_variant 1/1

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD4 exome
AF:
0.00000456
AC:
5
AN:
1097557
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
1
AN XY:
363097
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000594
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
22

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 09, 2024The c.74T>A (p.I25N) alteration is located in exon 3 (coding exon 1) of the AGTR2 gene. This alteration results from a T to A substitution at nucleotide position 74, causing the isoleucine (I) at amino acid position 25 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
3.0
DANN
Benign
0.76
DEOGEN2
Benign
0.16
T
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.48
T
M_CAP
Benign
0.0087
T
MetaRNN
Benign
0.073
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
N
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.10
N
REVEL
Benign
0.058
Sift
Benign
0.21
T
Sift4G
Benign
0.41
T
Polyphen
0.0
B
Vest4
0.17
MutPred
0.49
Gain of disorder (P = 0.0026);
MVP
0.57
MPC
0.25
ClinPred
0.020
T
GERP RS
1.6
Varity_R
0.051
gMVP
0.30

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chrX-115303607; API